Does PALBOCICLIB Cause Alopecia? 6,201 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6,201 reports of Alopecia have been filed in association with PALBOCICLIB (Ibrance). This represents 6.8% of all adverse event reports for PALBOCICLIB.
6,201
Reports of Alopecia with PALBOCICLIB
6.8%
of all PALBOCICLIB reports
137
Deaths
619
Hospitalizations
How Dangerous Is Alopecia From PALBOCICLIB?
Of the 6,201 reports, 137 (2.2%) resulted in death, 619 (10.0%) required hospitalization, and 15 (0.2%) were considered life-threatening.
Is Alopecia Listed in the Official Label?
Yes, Alopecia is listed as a known adverse reaction in the official FDA drug label for PALBOCICLIB.
What Other Side Effects Does PALBOCICLIB Cause?
Fatigue (15,190)
White blood cell count decreased (11,273)
Neoplasm progression (10,885)
Death (8,410)
Nausea (8,189)
Neutropenia (6,423)
Diarrhoea (5,635)
Asthenia (3,660)
Off label use (3,405)
Decreased appetite (3,400)
What Other Drugs Cause Alopecia?
DOCETAXEL (29,347)
METHOTREXATE (14,360)
ADALIMUMAB (13,726)
ETANERCEPT (11,390)
INFLIXIMAB (10,374)
LEFLUNOMIDE (10,267)
RITUXIMAB (10,119)
ABATACEPT (10,043)
TOCILIZUMAB (9,680)
HYDROXYCHLOROQUINE (9,653)
Which PALBOCICLIB Alternatives Have Lower Alopecia Risk?
PALBOCICLIB vs PALIPERIDONE
PALBOCICLIB vs PALIVIZUMAB
PALBOCICLIB vs PALONOSETRON
PALBOCICLIB vs PAMIDRONATE
PALBOCICLIB vs PAMIDRONIC ACID